Heart disease in pregnancy

Medicine

Volumn 34, Issue 8, 2006, Pages 307-311

  Carroll, Aisling J ^a,b   Thorne, Sara A ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b is the Lead on pregnancy in heart disease Conflicts of interest: none declared ^*  (United Kingdom)

Author keywords

heart disease; ischaemic heart disease; peripartum cardiomyopathy; pregnancy; pulmonary hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; ETONOGESTREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN; VASODILATOR AGENT; WARFARIN;

AORTA COARCTATION; AORTA OCCLUSION; AORTA STENOSIS; BED REST; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; DRUG CHOICE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FALLOT TETRALOGY; FETOTOXICITY; FONTAN PROCEDURE; GREAT VESSELS TRANSPOSITION; HEART DISEASE; HIGH RISK PREGNANCY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MARFAN SYNDROME; MATERNAL MORTALITY; MITRAL VALVE STENOSIS; MUSTARD OPERATION; OSTEOPOROSIS; OXYGEN THERAPY; PATIENT COUNSELING; PATIENT MONITORING; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; TERATOGENICITY; THORAX PAIN; THROMBOCYTOPENIA; VALVULAR HEART DISEASE;

EID: 33845387229     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.mpmed.2006.05.003     Document Type: Review

References (14)

1. Lewis G., and Drife J.O. Why mothers die 2000-2004. Confidential enquiry into maternal and child health (2005), RCOG press, London. www.cemach.org.uk/publications.htm
2. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24 (2003) 761-781
3. Shade Jr. G.H., Ross G., Bever F.N., Uddin Z., Devireddy L., and Gardin J.M. Troponin I in the diagnosis of acute myocardial infarction in pregnancy, labor, and post partum. Am J Obstet Gynecol 187 (2002) 1719-1720
4. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with post-partum cardiomyopathy. New Engl J Med 355 (2001) 1567-1571
5. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: NIH workshop recommendations and review. JAMA 283 (2000) 1183-1188
6. Autore C., Conte M.R., Piccininno M., et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 1864-1869
7. Chan W.S., Anand S., and Ginsberg J.S. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160 (2000) 191-196
8. Cotrufo M., de Feo M., de Santo L.S., et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 99 (2002) 35-40
9. Greer I.A., and Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106 (2005) 401-407
10. Oran B., Lee-Parritz A., and Ansell A. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic heart valves during pregnancy. Thromb Haemost 92 (2004) 747-751
11. Beauchesne L.M., Connolly H.M., Ammash N.M., et al. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 38 (2001) 1728-1733
12. Veldtman G., Connolly H., Grogan M., et al. Outcomes of pregnancy in women with Tetralogy of Fallot. J Am Coll Cardiol 44 (2004) 174-180
13. Thorne S.A. Pregnancy in heart disease. Heart 90 (2004) 450-456
14. Canobbio M.M., Mair D.D., van der Velde M., and Koos B.J.K. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 28 (1996) 763-767